Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity. | Int J Mol Sci | 2021 | 35008795 | PubTator, text mining | PubMed |
| E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors. | Cancers (Basel) | 2021 | 35008338 | PubTator, text mining | PubMed |
| Tumor metastasis: Mechanistic insights and therapeutic interventions. | MedComm (2020) | 2021 | 34977870 | PubTator, text mining | PubMed |
| Inhibitory Effect of Astaxanthin on Gene Expression Changes in Helicobacter pylori-Infected Human Gastric Epithelial Cells. | Nutrients | 2021 | 34959833 | PubTator, text mining | PubMed |
| Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Front Public Health | 2021 | 34950627 | PubTator, text mining | PubMed |
| Molecular Targets of Natural Compounds with Anti-Cancer Properties. | Int J Mol Sci | 2021 | 34948455 | PubTator, text mining | PubMed |
| Pillars and Gaps of S-Nitrosylation-Dependent Epigenetic Regulation in Physiology and Cancer. | Life (Basel) | 2021 | 34947954 | PubTator, text mining | PubMed |
| Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers. | Cancers (Basel) | 2021 | 34944799 | PubTator, text mining | PubMed |
| Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs. | Biomedicines | 2021 | 34944663 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia. | Cells | 2021 | 34943855 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. | Mol Cancer | 2021 | 34930302 | PubTator, text mining | PubMed |
| Kinetic Characterization of Human Histone Deacetylase 8 With Medium-Chain Fatty Acyl Lysine. | Epigenet Insights | 2021 | 34917889 | PubTator, text mining | PubMed |
| Expression of histone deacetylase (HDAC) family members in bortezomib-refractory multiple myeloma and modulation by panobinostat. | Cancer Drug Resist | 2021 | 34888496 | PubTator, text mining | PubMed |
| Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease. | Front Pharmacol | 2021 | 34887768 | PubTator, text mining | PubMed |
| The Effect of Organoselenium Compounds on Histone Deacetylase Inhibition and Their Potential for Cancer Therapy. | Int J Mol Sci | 2021 | 34884764 | PubTator, text mining | PubMed |
| Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis. | Cell Metab | 2021 | 34847376 | PubTator, text mining | PubMed |
| Histone deacetylase 8 interacts with the GTPase SmRho1 in Schistosoma mansoni. | PLoS Negl Trop Dis | 2021 | 34843489 | PubTator, text mining | PubMed |
| Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms. | Nutrients | 2021 | 34836197 | PubTator, text mining | PubMed |
| Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates. | Nutrients | 2021 | 34835969 | PubTator, text mining | PubMed |
| The Antileukemic Effect of Xestoquinone, A Marine-Derived Polycyclic Quinone-Type Metabolite, Is Mediated through ROS-Induced Inhibition of HSP-90. | Molecules | 2021 | 34834129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=45